TMCnet News
2018 Advancements in the Protein Targets Discovery Market - ResearchAndMarkets.comThe "Advancements in Protein Targets Discovery" report has been added to ResearchAndMarkets.com's offering. This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across new technologies enabling the discovery of novel protein targets. The service encompasses innovations enabling protein target discovery, complement system activation, allosteric protein modulation, protein therapeutics, and targeted antibody treatments. Additionally, this TOE provides analysis of clinical trial studies for protein therapies. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profile include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. Key Topics Covered:
For more information about this report visit https://www.researchandmarkets.com/research/cjflqg/2018_advancements?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180119005453/en/ |